Provided by Tiger Trade Technology Pte. Ltd.

Mesoblast

15.20
+0.22001.47%
Post-market: 15.19-0.0100-0.07%16:19 EDT
Volume:115.56K
Turnover:1.76M
Market Cap:1.95B
PE:-20.65
High:15.37
Open:15.11
Low:15.08
Close:14.98
52wk High:21.50
52wk Low:9.88
Shares:128.30M
Float Shares:78.65M
Volume Ratio:0.71
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7359
EPS(LYR):-0.8457
ROE:-18.22%
ROA:-6.16%
PB:3.39
PE(LYR):-17.97

Loading ...

Mesoblast Says Nearly $100 Million in Revenue Generated During First Year of Ryoncil Launch; Shares Fall 5%

MT Newswires Live
·
Apr 30

Press Release: Mesoblast Reports Ryoncil(R) Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million

Dow Jones
·
Apr 30

Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain

GlobeNewswire
·
Apr 29

Mesoblast Hits Phase 3 Recruitment Milestone in Chronic Back Pain Push

TIPRANKS
·
Apr 29

Mesoblast Details April Equity Issuance Moves and Director Share Purchases

TIPRANKS
·
Apr 17

Mesoblast Reports Lapse of 723,666 Options, Reducing Potential Dilution

TIPRANKS
·
Apr 16

Mesoblast Seeks ASX Quotation for 3.05 Million New Shares

TIPRANKS
·
Apr 16

Mesoblast Issues 815,000 Unquoted Options Under Employee Incentive Scheme

TIPRANKS
·
Apr 16

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galmed Pharmaceuticals (GLMD), Neurocrine (NBIX) and Mesoblast (MESO)

TIPRANKS
·
Apr 15

Sector Update: Health Care

MT Newswires Live
·
Apr 15

Mesoblast Acquires Exclusive License to Chimeric Antigen Receptor Platform; Shares Up 7%

MT Newswires Live
·
Apr 15

BRIEF-Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products

Reuters
·
Apr 15

Mesoblast Secures CAR Platform to Sharpen Targeting of Cell Therapies

TIPRANKS
·
Apr 15

Mesoblast Ltd - Obtains Worldwide Exclusive Rights to Car-MSC Ip From Mayo Clinic

THOMSON REUTERS
·
Apr 15

Mesoblast Ltd - to Incorporate Engineered Cars to Enhance Product Specificity

THOMSON REUTERS
·
Apr 15

Mesoblast Insider Makes Bold Multimillion-Dollar Move Into Company Stock

TIPRANKS
·
Apr 14

Top Mesoblast Insider Makes Massive New Bet on the Company’s Future

TIPRANKS
·
Apr 11

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION

GlobeNewswire
·
Apr 11

Mesoblast (MESO) Gets a Buy from Piper Sandler

TIPRANKS
·
Apr 10

Mesoblast's Fiscal 2026 Net Revenue Projected to be Up to $120 Million, Jefferies Says

MT Newswires Live
·
Apr 10